Guidelines for clinical trials in Helicobacter pylori infection

Gut

Volumn 41, Issue SUPPL. 2, 1997, Pages

  Axon, Anthony ^a   Deltenre, Michel ^b   Eriksson, Sven ^c   Fiocca, Roberto ^d   Glupczynski, Youri ^e   Hirschl, Alexander M ^f   Hunt, Richard ^g   Kimura, Ken ^h   Logan, Robert ⁱ   Malfertheiner, Peter ^j   Mégraud, Francis ^k   O'Morain, Colm ^l   Garcia, José Pajarès ^m   Rauws, Eric ⁿ   Rune, Simon ^o   Shimoyama, Takashi ^p   Unge, Peter ^q   Walan, Anders ^c   Ulf Westblom, T ^r  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^f UNIVERSITY OF VIENNA   (Austria)

^g MCMASTER UNIVERSITY   (Canada)

^h JICHI MEDICAL UNIVERSITY   (Japan)

ⁱ NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^j OTTO VON GUERICKE UNIVERSITY   (Germany)

^k HÔPITAL PELLEGRIN   (France)

^l ADELAIDE AND MEATH HOSPITAL   (Ireland)

^m HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

ⁿ ACADEMIC MEDICAL CENTER   (Netherlands)

^o GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^p HYOGO COLLEGE OF MEDICINE   (Japan)

^q Sandvikens Hospital   (Sweden)

^r TEXAS A AND M UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DATA ANALYSIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; MEDICAL ETHICS; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; STATISTICAL ANALYSIS;

CLINICAL TRIALS; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 12644282537     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. EEC Note for Guidance: Good Clinical Practice for Trials on Medicinal Products in the European Community. Pharmacol Toxicol 1990;67:361-72.
2. European GCP Guidelines. Surrey: Brookwood Medical Publications Ltd, 1993.
3. Beam TR, Gilbert DN, Kunin CM. General guidelines for the clinical evaluation of anti-infective drug products. Clin Infect Dis 1992;15(suppl 1):S5-32.
4. Murray DM, DuPont HL, Cooperstock M, Corrado ML, Fekery R. Evaluation of new anti-infective drugs for the treatment of gastritis and peptic ulcer disease associated with infection by Helicobacter pylori. Clin Infect Dis 1992; 15(suppl 1):S268-73.
5. Hunt SM, McKenna SP, Williams J. Reliability of a population survey tool for measuring perceived health problems: a study of patients with osteoarthrosis. J Epidemiol Community Health 1981;335:297-300.
6. Dupuy HJ. The Psychological General Well-being (PGWB) Index. In: Wenger NK, Mattson ME, Furberg CF, Elinson J, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq Publishing Inc., 1984:170-83.
7. Brazier JE, Harper R, Jones NMB, et al. Validating the SF-36 health survey questionnaire. New outcome measure for primary care. BMJ 1992;305:160-4.
8. Svedlund J, Sjödin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-34.
9. ICH harmonised tripartite guideline for E2A: Clinical safety data management: Definitions and standards for expedited reporting. Step 4 of the ICH Process. Final draft signed off by the Steering Committee signatories for the Regulatory Parties of International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Draft 10, 25 October 1994.
10. Talley N. Functional dyspepsia and H. pylori: a controversial link. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: Basic mechanisms to clinical cure. Boston: Kluwer, 1994: 437-48.
11. Veldhuyzen van Zanten SJO, Tytgat KMAJ, Pollak FT, et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori? J Clin Epidemiol 1993;46:273-9.
12. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to bio-medical journals. JAMA 1993;269:2282-6.
13. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to bio-medical journals. BMJ 1991;302:67-72.
14. Gardner MJ, Machin D, Campbell MJ. Use of checklists in assessing the statistical content of medical studies. BMJ 1986;292:810-2.
15. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting randomised controlled trials. JAMA 1996;276:637-9.